These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6110289)

  • 1. [The effects of furosemide on beta-blocker-induced hemodynamic changes in patients with hypertension (author's transl)].
    Nechwatal W; Hacker H; Greding H; Isbary J; König E; Stauch M
    Z Kardiol; 1980 Nov; 69(11):763-70. PubMed ID: 6110289
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension.
    Suonio S; Saarikoski S; Tahvanainen K; Pääkkönen A; Olkkonen H
    Am J Obstet Gynecol; 1986 Jul; 155(1):122-5. PubMed ID: 3728580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of oxprenolol in hypertensive patients.
    Majid PA; Sharma B; Saxton C; Stoker JB; Taylor SH
    Postgrad Med J; 1970 Nov; ():Suppl:67-72. PubMed ID: 4395462
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of cardiovascular responses to emotional stress in preventive cardiology (author's transl)].
    Slabý A; Frantík E; Horváth M; Josífko M
    Cas Lek Cesk; 1981 Nov; 120(46):1393-8. PubMed ID: 6119155
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)].
    Lehmann HU; Witt E; Hochrein H
    MMW Munch Med Wochenschr; 1978 Jun; 120(23):803-6. PubMed ID: 26870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The advantage of hemodynamic investigations in the treatment of arterial hypertensions (author's transl)].
    Carré A; Bertrand ME; Lablanche JM; Laisne C; Ginestet A; Lekieffre J
    Ann Cardiol Angeiol (Paris); 1978 Dec; 27(7):511-8. PubMed ID: 34351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peripheral vascular effects of metoprolol, pindolol and propranolol in hypertensive patients].
    Joyal F; Bourque M; Kuchel O; Larochelle P
    J Pharmacol; 1983; 14 Suppl 2():107-15. PubMed ID: 6138462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Human pharmacological studies on the hemodynamic effects of a new beta-adrenergic antagonist (bufuralol-Hcl).
    Magometschnigg D; Korn A; Bonelli J; Hitzenberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R95. PubMed ID: 238156
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic effects of a new inhibitor of adrenergic beta receptors (LB 46)].
    Lejwi G; Fabiato A; Gut JP; Gourgon R
    Arch Mal Coeur Vaiss; 1971 Nov; 64(11):1654-68. PubMed ID: 4402388
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical pharmacology of beta-adrenoceptor blocking drugs and therapeutic use in hypertension (author's transl)].
    Ebihara A
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):297-312. PubMed ID: 6103912
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of beta-adrenoceptor antagonists on central haemodynamics in essential hypertension.
    Tsukiyama H; Otsuka K; Higuma K
    Br J Clin Pharmacol; 1982; 13(Suppl 2):269S-278S. PubMed ID: 6125176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effects of a new beta-receptor blocking agent in patients with myocardial infarct].
    Heller A; Grosser KD; Fölsch E
    Med Welt; 1973 Dec; 24(49):1941-4. PubMed ID: 4149779
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
    Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
    Pharmacotherapy; 2006 Sep; 26(9):1247-54. PubMed ID: 16945046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic blood pressure control and middle cerebral artery mean blood velocity variability at rest and during exercise in humans.
    Ogoh S; Dalsgaard MK; Secher NH; Raven PB
    Acta Physiol (Oxf); 2007 Sep; 191(1):3-14. PubMed ID: 17506866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effects of hydralazine at rest and during exercise, in patients with congestive heart failure (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Stockins B; Saavedra J; Schulthess L
    Rev Med Chil; 1980 Jul; 108(7):599-604. PubMed ID: 7209179
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.